MedTrace Logo

Evaluation of Excellence in Italy's Residence for Execution of Security Measure

NCT06018298 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 245

Last updated 2023-09-06

No results posted yet for this study

Summary

The model of care for forensic psychiatry in Italy was changed by law (Law 81/2014) so that the six legacy secure forensic hospitals (Judicial Psychiatric Hospitals, OPG) were closed and new secure community residences for the execution of security measures (REMS) were opened in each of the 20 regions of Italy. This transition was in place by 2015. This observational study evaluates the health gains for patients both previously in OPGs and those admitted first to REMS. Health gains assessed include recovery measured by symptoms, function, need for therapeutic security and recovery of legal autonomy.

Conditions

  • Mental Disorder
  • Recovery
  • Schizophrenia and Related Disorders
  • Personality Disorders and Disturbances in Behavior
  • Personality Disorders, Antisocial
  • Intellectual Disability, Mild to Moderate

Interventions

OTHER

Treatment as usual (TAU)

the components of treatment as usual (TAU) are summarised and assessed by the items of the DUNDRUM-3: physical health, mental health, substance misuse, problem behaviours, self care and activities of daily living, education occupation and creativity, family and intimacy.

Sponsors & Collaborators

  • University of Dublin, Trinity College

    collaborator OTHER

  • University of Bari

    lead OTHER

Principal Investigators

  • Felice F Carabellese, MD · University of Bari

  • Lia Parente, PsyD · University of Bari

  • Harry G Kennedy, MD · University of Dublin Trinity College (TCD)

  • Mary Davoren, MD · University of Dublin Trinity College (TCD)

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-07-01
Primary Completion
2022-12-03
Completion
2022-12-03

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06018298 on ClinicalTrials.gov